CLINICAL ROLE -
Early View of Ampyra and Gilenya Use by MS Patients
Uptake of the new oral agents gilenya and Ampyra may be expected to increase rapidly in the future, if for largely different reasons.
2010 Drug Utilization and Cost Trends for Antidiabetic Agents
The antihyperglycemic therapeutic class will continue to be a major contributor to prescription drug trends in 2011 and beyond.
2 Clarke Drive Cranbury, NJ 08512